During the past decade, CF Therapeutics Development Center of Western New York conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "CF Therapeutics Development Center of Western New York" are "Cystic Fibrosis" (5 trials). Many other conditions were trialed in "CF Therapeutics Development Center of Western New York" in a lesser frequency.

Most popular intervention types in "CF Therapeutics Development Center of Western New York" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "IVA" (5 trials), "ELX/TEZ/IVA" (3 trials), "Placebo (matched to ELX/TEZ/IVA)" (2 trials), "Placebo (matched to IVA)" (2 trials) and "Placebo (matched to VX-121/TEZ/D-IVA)" (2 trials). Other intervention names were less common.

The vast majority of trials in "CF Therapeutics Development Center of Western New York" are 5 trials for "All" genders.

Currently, there are NaN active trials in "CF Therapeutics Development Center of Western New York". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in CF Therapeutics Development Center of Western New York, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in CF Therapeutics Development Center of Western New York, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".